Professor, I would like us to talk about patients being treated for drug-resistant depression. A drug program for this group of patients was launched last July. Can we already say what has happened over this past year?
This is a tremendous event for us, the psychiatric community nationwide, for the reason that it has brought the first drug program into our field that can finally offer patients with this thankless disease a therapeutic outlet. Patients with drug-resistant depression often do not respond to subsequent lines of treatment, the kind of standard therapeutic steps we take in treating any depression. And even combinations of different drugs don't transfer much, don't change their condition. They are often stuck in this suffering for months or even years. They are ...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
